The time has finally come when researchers have found a way to harness the immune system and use it to fight blood cancers.
To halt the rise of anal cancer, everyone eligible needs to be vaccinated against HPV, which causes most cases of the disease.
An Extraordinary Healer essay honoring WYNDELON “NIKKI” SIMMONS, B.S.N., RN, OCN [UNIVERSITY OF MISSISSIPPI MEDICAL CENTER CANCER INSTITUTE, JACKSON, MISSISSIPPI]
The nomination essay for CURE® Extraordinary Healer Award for Oncology Nursing finalist, Barbara Bittner, RN, OCN. Written by Dianne Rohald, AdventHealth Cancer Institute and Charlene’s Dream.
Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.
Patients with non-muscle invasive bladder cancer experience high levels of distress, according to one study.
An Extraordinary Healer essay honoring MONIQUE CLAYTON, B.S.N. [SOCIAL CLINICAL RESEARCH SPECIALIST AND STUDY COORDINATOR, LINEBERGER COMPREHENSIVE CANCER CENTER, CHAPEL HILL, NORTH CAROLINA]
Radhakrishnan Ramchandren, M.D., from the Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, discusses the role of clinical trials in developing news drugs and standards of care for patients with lymphoma.
After realizing how little awareness there was about MPNs, one advocate looked to his TV background to help.
There are some key discussions that men with metastatic prostate cancer should have with their health care providers.
When others assume that patients with lung cancer must have smoked to get the disease, this stigma can affect patient outcomes.
An oncology nurse navigator writes about her patient's journey with ovarian cancer.
After treatment for stage 4 colorectal cancer, a country singer is using his talents to express his gratitude and help others.
Beware of the possible privacy pitfalls of befriending your nurse on social media.
Physical activity may be as powerful as anything that comes from a bottle, but how much and how often is as individual as every pill in your medicine cabinet.
Trilaciclib, an intravenous CDK 4/6 inhibitor, in combination with Hycamtin may reduce chemotherapy-induced myelosuppression in small cell lung cancer, according to one expert.
Jeffrey Holzbeierlein, M.D., University of Kansas Medical Center, discusses how important it was that a multidisciplinary team came together to create the non-metastatic muscle-invasive bladder cancer guidelines.
International Nonprofit Provides 126K+ Swabs Globally to Help Fight Virus
Despite the challenges of diagnosing and treating liposarcoma and chondrosarcoma, experts are optimistic about future treatments for these two rare cancers.